Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.6.5 is added to the study's revision history, and the previous revision v3.6.4 is removed. This reflects an update to the record's version history without altering the trial data.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded revision v3.6.4 to the history and removed v3.6.3, reflecting a small update to the page’s version history.SummaryDifference0.1%

- Check62 days agoChange DetectedA newer revision entry (v3.6.3) was added to the record history and an older revision (v3.6.0) was removed, updating the history to reflect the latest version.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study record shows recruitment has closed to new participants and the record has been revised to version v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.4%

- Check84 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the study history page.SummaryDifference0.1%

- Check105 days agoChange DetectedThe bottom revision stamp updates from v3.5.3 to v3.5.4, reflecting a new revision of the record history. This indicates the study record has been updated.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.